DMK
CCXI

David M. Knott’s ChemoCentryx, Inc. CCXI Stock Holding History

David M. Knott’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,587
Closed -$361K – 117
2020
Q3 		$361K Sell
6,587
-68,446
-91% -$3.69M 0.21% 57
2020
Q2 		$4.32M Sell
75,033
-25,398
-25% -$1.38M 2.36% 10
2020
Q1 		$4.04M Sell
100,431
-5,644
-5% -$240K 2.55% 10
2019
Q4 		$4.2M Buy
106,075
+101,075
+2,022% +$1.77M 1.7% 15
2019
Q3 		$34K Buy
+5,000
New +$37.5K 0.01% 105

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

David M. Knott's CCXI Position: Q4 2020 in Review

David M. Knott sold out of ChemoCentryx, Inc. (CCXI) in Q4 2020, closing a stake of 6,587 shares — an estimated $361K sold.

David M. Knott first reported a position in CCXI in Q3 2019 and held it in 5 quarters. The position peaked at $4.32M in Q2 2020. 196 funds tracked by Wall St. Rank hold CCXI as of Q4 2020.

  • David M. Knott reported no remaining ChemoCentryx, Inc. position as of Q4 2020 after selling out during the quarter.
  • David M. Knott sold 6,587 ChemoCentryx, Inc. shares in Q4 2020, an estimated $361K.
  • David M. Knott first reported a position in ChemoCentryx, Inc. in Q3 2019 and held it in 5 quarters.
  • David M. Knott's ChemoCentryx, Inc. position peaked at $4.32M in Q2 2020.
  • 196 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2020.

Based on David M. Knott's 13F filing for Q4 2020, filed 12 Feb 2021.